QMS Medical Allied Services Limited
All news and filings related to QMS Medical Allied Services Limited.
View all news & filings- High impact
QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare for ₹14.225 Crore
QMS Medical Allied Services Ltd has completed the 100% acquisition of Saarathi Healthcare Pvt Ltd for ₹14.225 crore. This move integrates Saarathi's disease management and patient engagement capabilities with QMS MAS's screening and diagnostics services. The company aims to build a comprehensive healthcare platform and has a revenue target of ₹500 crore by FY29.
Read the summary - Medium impact
QMS Medical Allied Services Acquires 24% Stake in Saarathi Healthcare, Now Holds 100%
QMS Medical Allied Services Limited (QMSMEDI) acquired an additional 24% stake in Saarathi Healthcare Private Limited, increasing its ownership to 100%. The cash consideration for the acquisition was ₹14,22,50,000. This move expands QMSMEDI's presence in the healthcare services sector.
Read the summary - Low impact
QMS Medi Announces 9th AGM on Sep 30, 2026, with E-voting Facility
QMS Medical Allied Services Limited will hold its 9th AGM on September 30, 2026, via video conference. Annual Report for FY26 dispatched. E-voting facility available from Sept 23 to Sept 29, 2026. Details on company website and BSE/NSDL.
Read the summary - Low impact
QMS Medical Allied Services Limited Disseminates Annual Report 2025-26 and AGM Notice
QMS Medical Allied Services Limited has disseminated its Annual Report for FY 2025-26 and the Notice for its 9th AGM. Shareholders without registered emails are provided with a web-link to access these documents. The company is adhering to SEBI Listing Regulations for this disclosure.
Read the summary - Low impact
QMS Medical Allied Services: Record Date Set for 9th AGM and Dividend Payment
QMS Medical Allied Services Limited has set September 23, 2026, as the record date for its 9th AGM and dividend payment. The book closure period is from September 24 to September 30, 2026. The AGM is on September 30, 2026, with dividend payments expected from October 5, 2026.
Read the summary - Medium impact
QMS Medical Allied Services Announces 9th AGM on Sep 30, 2026; Recommends Dividend
QMS Medical Allied Services will hold its 9th AGM on September 30, 2026, to adopt FY26 financial statements and recommend a dividend of ₹0.50 per share. The AGM will also approve the appointment of Mr. Pranav Manhar Badheka as an Independent Director and related party transactions up to ₹20 crore with its subsidiary.
Read the summary - Medium impact
QMS Medi Appoints Pranav Manhar Badheka as Additional Independent Director
QMS Medical Allied Services Limited appointed Mr. Pranav Manhar Badheka as Additional Non-Executive Independent Director for five years from September 03, 2026. The company also approved material related party transactions with subsidiary Saarathi Healthcare Private Limited. The 9th AGM is scheduled for September 30, 2026, with e-voting from September 27-29, 2026.
Read the summary - High impact
QMS Medical Allied Services signs 5-year exclusive distribution deal with HEINE Optotechnik for India
QMS Medical Allied Services Limited signed a five-year exclusive distribution agreement with HEINE Optotechnik for India, starting January 1, 2027. HEINE's 2026 Indian revenue was ~€2.6 million (~₹30 crore), with expectations to reach ₹70 crore by 2031. QMS aims to surpass ₹500 crore revenue by FY29.
Read the summary - Medium impact
QMS Medical Allied Services Q1 FY27 Earnings Call Transcript Released
QMS Medical Allied Services reported Q1 FY27 consolidated revenue of ₹56.9 crore (up 22% YoY) and PAT of ₹4 crore (up 25% YoY). EBITDA grew 27% to ₹8.3 crore. The company generated ₹17 crore from PSP services and conducted 11,497 B2B health camps. They are acquiring the remaining stake in Saarathi Healthcare by Q2 FY27 and expect FY27 PSP revenue between ₹90-105 crore.
Read the summary - Medium impact
QMS Medical Allied Services Achieves Gold Cybersecurity Certification
QMS Medical Allied Services Ltd achieved "Gold" cybersecurity certification for 2026 with a score of 918/1000. The certification, valid until August 17, 2027, signifies a "Mature" cybersecurity maturity level and is crucial for client trust and risk mitigation in the healthcare sector.
Read the summary - Low impact
QMS Medi Releases Q1 FY27 Earning Call Recording
QMS Medical Allied Services Limited released the audio recording of its Q1 FY27 earning call held on August 17, 2026. The results were approved by the board on August 14, 2026. A link to the recording and investor presentation is available on the company website.
Read the summary - Low impact
QMS Medical Allied Services Ltd Issues Revised Investor Presentation for Q1FY27
QMS Medical Allied Services Ltd released a revised investor presentation for Q1FY27 after identifying typographical errors. The company reported Q1FY27 revenue of ₹56.9 crore (up 22% YoY) and PAT of ₹4 crore (up 25% YoY). They plan to acquire the remaining stake in Saarathi Healthcare by Q2FY27.
Read the summary - Medium impact
QMS Medical Allied Services Releases Investor Presentation Highlighting Q1FY27 Growth
QMS Medical Allied Services reported Q1FY27 consolidated revenue of ₹56.9 crore, up 22% YoY. EBITDA grew 27% to ₹8.3 crore, with margins at 14.6%. PAT increased 25% to ₹4 crore. The company plans to acquire the remaining stake in Saarathi Healthcare by end of Q2FY27. Annual revenues grew to ₹172.9 crore in FY26.
Read the summary - Low impact
QMS Medi Announces Publication of Q1 FY27 Unaudited Financial Results
QMS Medical Allied Services Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were published on August 15, 2026, and are available on the company's website. The Board of Directors approved these results on August 14, 2026.
Read the summary - Low impact
QMS Medical Allied Services Ltd. Schedules Q1 FY27 Earnings Conference Call for August 17, 2026
QMS Medical Allied Services Ltd. will host an Earnings Conference Call on August 17, 2026, at 12:00 PM IST to discuss financial results for the quarter ended June 30, 2026. Management representatives include Mr. Mahesh Makhija and Mr. Mohit Tamhankar.
Read the summary - Low impact
QMS Medical Allied Services to Meet Ashika Investment Managers on Aug 19, 2026
QMS Medical Allied Services Limited officials will meet with Ashika Investment Managers AIF on August 19, 2026. The meeting is an in-person, one-on-one interaction. The company will discuss publicly available information only, with no unpublished price-sensitive information to be disclosed.
Read the summary - Low impact
QMS Medi Schedules Q1 FY27 Earnings Conference Call for August 17, 2026
QMS Medical Allied Services Limited will host an Earnings Conference Call on Monday, August 17, 2026, at 12:00 PM IST to discuss financial results for the quarter ended June 30, 2026. Management representatives, including the Chairman & Managing Director, will participate.
Read the summary - Medium impact
QMS Medi Subsidiary Saarathi Healthcare Receives SOC 2 Type II Certificate
QMS Medical Allied Services Limited's subsidiary, Saarathi Healthcare Private Limited, has received a SOC 2 Type II Certificate. This certification validates the effectiveness of its information security and data protection controls for a period of 5 years, reinforcing its commitment to robust standards in healthcare support operations.
Read the summary - Low impact
QMS Medical Allied Services: Certificate under SEBI Reg 74(5) for Q1FY27
QMS Medical Allied Services Limited received a certificate for the quarter ended June 30, 2026, under SEBI regulations. The company's entire shareholding is in demat form, with no rematerialisation requests received by the RTA.
Read the summary - Low impact
QMS Medical Allied Services Limited Closes Trading Window from July 1, 2026
QMS Medical Allied Services Limited will close its trading window from July 1, 2026, until 48 hours after the announcement of Q1 FY27 results. This is a routine compliance measure under SEBI regulations.
Read the summary - High impact
QMS Medical Allied Services Migrates to NSE Mainboard; Targets Rs. 500 Crore Revenue by FY29
QMS Medical Allied Services Limited has migrated to the NSE Mainboard, effective June 18, 2026. The company reported FY26 consolidated revenues of ₹172.9 crore and EBITDA of ₹25.9 crore. QMS aims to reach ₹500 crore in consolidated revenue by FY29, with its Services business expected to double by FY27.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio